Putative tumour-suppressor gene DAB2 is frequently down regulated by promoter hypermethylation in nasopharyngeal carcinoma

BMC Cancer

Volumn 10, Issue , 2010, Pages

  Tong, Joanna H ^a   Ng, David C ^a   Chau, Shuk L ^a   So, Ken K ^a   Leung, Patrick P ^a   Lee, Tin L ^b   Lung, Raymond W ^a   Chan, Michael W ^c   Chan, Anthony W ^a   Lo, Kwok W ^a   To, Ka F ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^c NATIONAL CHUNG CHENG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; ADAPTOR PROTEIN; HUMAN DISABLED 2 PROTEIN; UNCLASSIFIED DRUG; AZACITIDINE; DAB2 PROTEIN, HUMAN; DNA METHYLTRANSFERASE; DRUG DERIVATIVE; HISTONE DEACETYLASE INHIBITOR; HYDROXAMIC ACID; MESSENGER RNA; PROTEIN C FOS; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TRICHOSTATIN A;

ARTICLE; CANCER GROWTH; CARCINOGENESIS; COLONY FORMATION; CONTROLLED STUDY; DNA METHYLATION; DNA SEQUENCE; DOWN REGULATION; GENE EXPRESSION PROFILING; GENE FUNCTION; GROWTH RATE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; NASOPHARYNX CARCINOMA; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIMARY TUMOR; PROMOTER REGION; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE; TUMOR XENOGRAFT; ADOLESCENT; ADULT; AGED; ANIMAL; CANCER TRANSPLANTATION; CARCINOMA; CELL ADHESION; CELL PROLIFERATION; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETIC TRANSFECTION; GENETICS; MALE; METABOLISM; MIDDLE AGED; MOUSE; NASOPHARYNX TUMOR; PATHOLOGY; TIME; TUMOR CELL LINE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; AZACITIDINE; CARCINOMA; CELL ADHESION; CELL LINE, TUMOR; CELL PROLIFERATION; DNA METHYLATION; DNA MODIFICATION METHYLASES; DOWN-REGULATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; GENES, TUMOR SUPPRESSOR; HISTONE DEACETYLASE INHIBITORS; HUMANS; HYDROXAMIC ACIDS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOPLASM TRANSPLANTATION; POLYMERASE CHAIN REACTION; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS C-FOS; RNA, MESSENGER; TIME FACTORS; TRANSFECTION; YOUNG ADULT;

EID: 77952989040     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-10-253     Document Type: Article

References (43)

1. Lo KW, To KF, Huang DP. Focus on nasopharyngeal carcinoma. Cancer Cell 2004, 5:423-428. 10.1016/S1535-6108(04)00119-9, 15144950.
2. Xu XX, Yi T, Tang B, Lambeth JD. Disabled-2 (Dab2) is an SH3 domain-binding partner of Grb2. Oncogene 1998, 16:1561-1569. 10.1038/sj.onc.1201678, 9569023.
3. Zhou J, Hsieh JT. The inhibitory role of DOC-2/DAB2 in growth factor receptor-mediated signal cascade. DOC-2/DAB2-mediated inhibition of ERK phosphorylation via binding to Grb2. J Biol Chem 2001, 276:27793-27798. 10.1074/jbc.M102803200, 11371563.
4. Morris SM, Arden SD, Roberts RC, Kendrick-Jones J, Cooper JA, Luzio JP, Buss F. Myosin VI binds to and localises with Dab2, potentially linking receptor-mediated endocytosis and the actin cytoskeleton. Traffic 2002, 3:331-341. 10.1034/j.1600-0854.2002.30503.x, 11967127.
5. Morris SM, Cooper JA. Disabled-2 colocalizes with the LDLR in clathrin-coated pits and interacts with AP-2. Traffic 2001, 2:111-123. 10.1034/j.1600-0854.2001.020206.x, 11247302.
6. Hocevar BA, Prunier C, Howe PH. Disabled-2 (Dab2) mediates transforming growth factor beta (TGFbeta)-stimulated fibronectin synthesis through TGFbeta-activated kinase 1 and activation of the JNK pathway. J Biol Chem 2005, 280:25920-25927. 10.1074/jbc.M501150200, 15894542.
7. Wang Z, Tseng CP, Pong RC, Chen H, McConnell JD, Navone N, Hsieh JT. The mechanism of growth-inhibitory effect of DOC-2/DAB2 in prostate cancer. Characterization of a novel GTPase-activating protein associated with N-terminal domain of DOC-2/DAB2. J Biol Chem 2002, 277:12622-12631. 10.1074/jbc.M110568200, 11812785.
8. Prunier C, Howe PH. Disable-2 (Dab-2) is required for transforming growth factor beta-induced epithelial to mesenchymal transition (EMT). J Biol Chem 2005, 280:17540-17548. 10.1074/jbc.M500974200, 15734730.
9. Hocevar BA, Mou F, Rennolds JL, Morris SM, Cooper JA, Howe PH. Regulation of the Wnt signaling pathway by disabled-2 (Dab2). Embo J 2003, 22:3084-3094. 10.1093/emboj/cdg286, 162138, 12805222.
10. Mok SC, Chan WY, Wong KK, Cheung KK, Lau CC, Ng SW, Baldini A, Colitti CV, Rock CO, Berkowitz RS. DOC-2, a candidate tumor suppressor gene in human epithelial ovarian cancer. Oncogene 1998, 16:2381-2387. 10.1038/sj.onc.1201769, 9620555.
11. Bagadi SA, Prasad CP, Srivastava A, Prashad R, Gupta SD, Ralhan R. Frequent loss of Dab2 protein and infrequent promoter hypermethylation in breast cancer. Breast Cancer Res Treat 2007, 104:277-286. 10.1007/s10549-006-9422-6, 17115114.
12. Fazili Z, Sun W, Mittelstaedt S, Cohen C, Xu XX. Disabled-2 inactivation is an early step in ovarian tumorigenicity. Oncogene 1999, 18:3104-3113. 10.1038/sj.onc.1202649, 10340382.
13. Tseng CP, Ely BD, Li Y, Pong RC, Hsieh JT. Regulation of rat DOC-2 gene during castration-induced rat ventral prostate degeneration and its growth inhibitory function in human prostatic carcinoma cells. Endocrinology 1998, 139:3542-3553. 10.1210/en.139.8.3542, 9681506.
14. Zhou J, Scholes J, Hsieh JT. Characterization of a novel negative regulator (DOC-2/DAB2) of c-Src in normal prostatic epithelium and cancer. J Biol Chem 2003, 278:6936-6941. 10.1074/jbc.M210628200, 12473651.
15. Anupam K, Tusharkant C, Gupta SD, Ranju R. Loss of disabled-2 expression is an early event in esophageal squamous tumorigenesis. World J Gastroenterol 2006, 12:6041-6045.
16. Karam JA, Shariat SF, Huang HY, Pong RC, Ashfaq R, Shapiro E, Lotan Y, Sagalowsky AI, Wu XR, Hsieh JT. Decreased DOC-2/DAB2 expression in urothelial carcinoma of the bladder. Clin Cancer Res 2007, 13:4400-4406. 10.1158/1078-0432.CCR-07-0287, 17671122.
17. Kleeff J, Huang Y, Mok SC, Zimmermann A, Friess H, Buchler MW. Down-regulation of DOC-2 in colorectal cancer points to its roles as a tumor suppressor in this malignancy. Dis Colon Rectum 2002, 45:1242-1248. 10.1007/s10350-004-6399-2, 12352243.
18. Fulop V, Colitti CV, Genest D, Berkowitz RS, Yiu GK, Ng SW, Szepesi J, Mok SC. DOC-2/hDab2, a candidate tumor suppressor gene involved in the development of gestational trophoblastic diseases. Oncogene 1998, 17:419-424. 10.1038/sj.onc.1201955, 9696034.
19. Zhou J, Hernandez G, Tu SW, Scholes J, Chen H, Tseng CP, Hsieh JT. Synergistic induction of DOC-2/DAB2 gene expression in transitional cell carcinoma in the presence of GATA6 and histone deacetylase inhibitor. Cancer Res 2005, 65:6089-6096. 10.1158/0008-5472.CAN-04-3672, 16024609.
20. Chow LS, Lo KW, Kwong J, To KF, Tsang KS, Lam CW, Dammann R, Huang DP. RASSF1A is a target tumor suppressor from 3p21.3 in nasopharyngeal carcinoma. Int J Cancer 2004, 109:839-847. 10.1002/ijc.20079, 15027117.
21. Tsao SW, Wang X, Liu Y, Cheung YC, Feng H, Zheng Z, Wong N, Yuen PW, Lo AK, Wong YC, Huang DP. Establishment of two immortalized nasopharyngeal epithelial cell lines using SV40 large T and HPV16E6/E7 viral oncogenes. Biochim Biophys Acta 2002, 1590:150-158. 10.1016/S0167-4889(02)00208-2, 12063178.
22. Yu J, Cheng YY, Tao Q, Cheung KF, Lam CN, Geng H, Tian LW, Wong YP, Tong JH, Ying JM, et al. Methylation of protocadherin 10, a novel tumor suppressor, is associated with poor prognosis in patients with gastric cancer. Gastroenterology 2009, 136:640-651. e641., 10.1053/j.gastro.2008.10.050, 19084528.
23. Tong JH, Tsang RK, Lo KW, Woo JK, Kwong J, Chan MW, Chang AR, van Hasselt CA, Huang DP, To KF. Quantitative Epstein-Barr virus DNA analysis and detection of gene promoter hypermethylation in nasopharyngeal (NP) brushing samples from patients with NP carcinoma. Clin Cancer Res 2002, 8:2612-2619.
24. Sheng Z, He J, Tuppen JA, Sun W, Fazili Z, Smith ER, Dong FB, Xu XX. Structure, sequence, and promoter analysis of human disabled-2 gene (DAB2). Genomics 2000, 70:381-386. 10.1006/geno.2000.6383, 11161789.
25. Zhoul J, Hernandez G, Tu SW, Huang CL, Tseng CP, Hsieh JT. The role of DOC-2/DAB2 in modulating androgen receptor-mediated cell growth via the nongenomic c-Src-mediated pathway in normal prostatic epithelium and cancer. Cancer Res 2005, 65:9906-9913. 10.1158/0008-5472.CAN-05-1481, 16267015.
26. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408. 10.1006/meth.2001.1262, 11846609.
27. Xu XX, Yang W, Jackowski S, Rock CO. Cloning of a novel phosphoprotein regulated by colony-stimulating factor 1 shares a domain with the Drosophila disabled gene product. J Biol Chem 1995, 270:14184-14191. 10.1074/jbc.270.23.14184, 7775479.
28. He J, Smith ER, Xu XX. Disabled-2 exerts its tumor suppressor activity by uncoupling c-Fos expression and MAP kinase activation. J Biol Chem 2001, 276:26814-26818. 10.1074/jbc.M101820200, 11359772.
29. Wong N, Hui AB, Fan B, Lo KW, Pang E, Leung SF, Huang DP, Johnson PJ. Molecular cytogenetic characterization of nasopharyngeal carcinoma cell lines and xenografts by comparative genomic hybridization and spectral karyotyping. Cancer Genet Cytogenet 2003, 140:124-132. 10.1016/S0165-4608(02)00657-X, 12645650.
30. Hui AB, Lo KW, Leung SF, Teo P, Fung MK, To KF, Wong N, Choi PH, Lee JC, Huang DP. Detection of recurrent chromosomal gains and losses in primary nasopharyngeal carcinoma by comparative genomic hybridisation. Int J Cancer 1999, 82:498-503. 10.1002/(SICI)1097-0215(19990812)82:4<498::AID-IJC5>3.0.CO;2-S, 10404061.
31. Lo KW, Teo PM, Hui AB, To KF, Tsang YS, Chan SY, Mak KF, Lee JC, Huang DP. High resolution allelotype of microdissected primary nasopharyngeal carcinoma. Cancer Res 2000, 60:3348-3353.
32. Akiyama Y, Watkins N, Suzuki H, Jair KW, van Engeland M, Esteller M, Sakai H, Ren CY, Yuasa Y, Herman JG, Baylin SB. GATA-4 and GATA-5 transcription factor genes and potential downstream antitumor target genes are epigenetically silenced in colorectal and gastric cancer. Mol Cell Biol 2003, 23:8429-8439. 10.1128/MCB.23.23.8429-8439.2003, 262684, 14612389.
33. Lo KW, Kwong J, Hui AB, Chan SY, To KF, Chan AS, Chow LS, Teo PM, Johnson PJ, Huang DP. High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma. Cancer Res 2001, 61:3877-3881.
34. Hui AB, Lo KW, Kwong J, Lam EC, Chan SY, Chow LS, Chan AS, Teo PM, Huang DP. Epigenetic inactivation of TSLC1 gene in nasopharyngeal carcinoma. Mol Carcinog 2003, 38:170-178. 10.1002/mc.10156, 14639656.
35. Kwong J, Lo KW, Chow LS, Chan FL, To KF, Huang DP. Silencing of the retinoid response gene TIG1 by promoter hypermethylation in nasopharyngeal carcinoma. Int J Cancer 2005, 113:386-392. 10.1002/ijc.20593, 15455391.
36. Kwong J, Chow LS, Wong AY, Hung WK, Chung GT, To KF, Chan FL, Daigo Y, Nakamura Y, Huang DP, Lo KW. Epigenetic inactivation of the deleted in lung and esophageal cancer 1 gene in nasopharyngeal carcinoma. Genes Chromosomes Cancer 2007, 46:171-180. 10.1002/gcc.20398, 17099870.
37. Fukayama M, Hino R, Uozaki H. Epstein-Barr virus and gastric carcinoma: virus-host interactions leading to carcinoma. Cancer Sci 2008, 99:1726-1733. 10.1111/j.1349-7006.2008.00888.x, 18616681.
38. Tsai CL, Li HP, Lu YJ, Hsueh C, Liang Y, Chen CL, Tsao SW, Tse KP, Yu JS, Chang YS. Activation of DNA methyltransferase 1 by EBV LMP1 Involves c-Jun NH(2)-terminal kinase signaling. Cancer Res 2006, 66:11668-11676. 10.1158/0008-5472.CAN-06-2194, 17178861.
39. Yang DH, Smith ER, Cai KQ, Xu XX. C-Fos elimination compensates for disabled-2 requirement in mouse extraembryonic endoderm development. Dev Dyn 2009, 238:514-523. 10.1002/dvdy.21856, 2743073, 19191218.
40. Jiang Y, Prunier C, Howe PH. The inhibitory effects of Disabled-2 (Dab2) on Wnt signaling are mediated through Axin. Oncogene 2008, 27:1865-1875. 10.1038/sj.onc.1210829, 2810718, 17922036.
41. Chou J, Lin YC, Kim J, You L, Xu Z, He B, Jablons DM. Nasopharyngeal carcinoma--review of the molecular mechanisms of tumorigenesis. Head Neck 2008, 30:946-963. 10.1002/hed.20833, 18446839.
42. Lee KS, Song S, Erikson RL. The polo-box-dependent induction of ectopic septal structures by a mammalian polo kinase, plk, in Saccharomyces cerevisiae. Proc Natl Acad Sci USA 1999, 96:14360-14365. 10.1073/pnas.96.25.14360, 24441, 10588710.
43. He J, Xu J, Xu XX, Hall RA. Cell cycle-dependent phosphorylation of Disabled-2 by cdc2. Oncogene 2003, 22:4524-4530. 10.1038/sj.onc.1206767, 12881709.